Targeting strategies with lipid vectors for nucleic acid supplementation therapy in Fabry disease: a systematic review
GSH levels in whole blood, erythrocytes, plasma and peripheral blood mononuclear cells (PBMCs) were assessed in 12 subjects at the baseline and after 1, 2 and 4 weeks of GSH administration
Cerebral folate deficiency and CNS inflammatory markers in Alpers disease
Once mixed, the solution is stable at 28C for 28 days, but every needle puncture introduces contamination risk, so using a vial within 21 days and minimizing punctures (one draw per dose, never re-injecting air) extends usable life
Mice exposed to altered light-dark cycles also exhibited disrupted Per2 rhythms alongside chronic inflammation characterized by elevated IL-1, IL-6, and TNF-, and changes in macrophage populations favoring pro-inflammatory phenotypes 126,202